Replies to post #15745 on Humanigen Inc (fka HGENQ)

[MWM]

I'm a novice Biotech trader but from what I can see this is a buyout target. No way you can't say Lenzilumab is not in the lead here concerning Covid/Cytokine Storm treatment. When the good news really starts, I don't see it stopping. $50-$100 potential...